Kim, Vy H. D.
Upton, Julia E. M.
Derfalvi, Beata
Hildebrand, Kyla J.
McCusker, Christine
Article History
Received: 29 July 2024
Accepted: 25 November 2024
First Online: 8 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Vy HD Kim is a medical advisory board member of Immunity Canada and is a clinical trial investigator for ALK-Abello and DBV Technologies. Dr. Julia Upton is a medical advisory board member of Immunodeficiency Canada, a member of the Board of Directors for the Canadian Society of Allergy and Clinical Immunology, clinical trial investigator for Sanofi/Regeneron, ALK-Abello and DBV Technologies, research support from Novartis, unrestricted educational honorarium from Astra Zeneca, and scientific advisory board member for Pharming Group N.V. and Pfizer. Dr. Beata Derfalvi is a medical advisory board member of Immunity Canada and Immunodeficiency Canada and scientific advisory board member for Pharming Group N.V. and Takeda. Dr. Kyla J. Hildebrand is a medical advisory board member of Immunity Canada, a member of the Board of Directors for the Canadian Society of Allergy and Clinical Immunology, and a voting member of the National Advisory Committee on Immunizations. Dr. Christine McCusker has been a scientific advisory board member for Baxter, CSL Behring and Talecris.